On Demand Drug Discovery: BIOVIA Connect AI, Molecular Modeling & Simulation

Talks from BIOVIA Connect on AI, molecular modelling and simulation in drug discovery, with speakers from the Cambridge Crystallographic Data Centre, VITRUVIAE, Cyrus Biotechnology and the OpenFold Consortium, Arizona State University, Université Paris Cité and BIOVIA. They cover designing molecules against pathogenic bacteria with machine learning, retrosynthesis for the medicinal chemist, in silico design of multi-specific protein therapeutics, the development of OpenFold3, AI prediction of nanobody epitopes and designing protein binders with BIOVIA.